NXTC·65343E207·US·equity·Healthcare - Biotechnology-Activist
NXTC (NEXTCURE INC) is held by 11 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($646,503), GEODE CAPITAL MANAGEMENT, LLC ($327,136), BlackRock, Inc. ($296,830). Net institutional sentiment: Mixed.
See how NXTC's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer